Related Experiment Video
Updated: Jun 27, 2026

05:47
Isolation of Murine Lymph Node Stromal Cells
Published on: August 19, 2014
Evaluation of lymph nodes with RECIST 1.1
L H Schwartz1, J Bogaerts, R Ford
1Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue (C-276D), New York, NY, USA. SchwartL@mskcc.org
Summary
New guidelines recommend measuring lymph nodes by short axis for accurate cancer staging. This standardized approach improves assessment of metastatic disease in solid tumors, preventing false progressions.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Lymph nodes are frequent sites for metastasis in solid tumors.
- Unlike typical metastases, lymph nodes are normal anatomical structures with measurable size.
- Short axis measurement of lymph nodes is recommended for reproducibility and predicting malignancy.
Purpose of the Study:
- To propose standardized guidelines for measuring lymph nodes in cancer response assessment.
- To categorize lymph nodes as normal or pathological (target/non-target lesions) based on size.
- To demonstrate the impact of these guidelines on response assessment using RECIST (Response Evaluation Criteria in Solid Tumors) data.
Main Methods:
- Lymph nodes are measured in their short axis.
- Specific measurement values and rules are proposed for categorizing lymph nodes.
- Data from the RECIST warehouse are used to evaluate the proposed guidelines.
Main Results:
- The proposed guidelines standardize lymph node measurement for improved accuracy.
- These rules help focus target lesion measurements on potentially metastatic nodes.
- The guidelines aim to prevent false progressions caused by minor size changes.
Conclusions:
- Standardized lymph node measurement guidelines enhance the accuracy of cancer staging and response assessment.
- Implementation of these rules facilitates easier assessment and reduces diagnostic errors.
- The guidelines improve the reliability of identifying metastatic disease in lymph nodes.

